Annovis Bio Nears Milestone in Alzheimer’s Treatment Study with Completion of Data Cleaning
MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS), a biotech firm focused on developing novel treatments for neurodegenerative diseases, announced the successful completion of data cleaning for its pivotal phase …
Annovis Bio Nears Milestone in Alzheimer’s Treatment Study with Completion of Data Cleaning Read More